Mano augintinis - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 314,289 | 352,124 | 387,153 | 432,310 | 452,898 | 507,017 | 549,393 | 571,274 |
| Profit before tax | 8,139 | 20,679 | 10,283 | 10,602 | -11,985 | 9,279 | 18,075 | 8,913 |
| Net profit | 6,916 | 17,574 | 8,921 | 10,602 | -11,985 | 8,861 | 17,665 | 7,567 |
| Equity | 44,506 | 61,109 | 70,713 | 81,331 | 69,257 | 77,161 | 94,827 | 102,394 |
| Liabilities | 28,620 | 42,226 | 36,924 | 114,757 | 103,491 | 92,353 | 56,934 | 44,504 |
| Non-current assets | 5,981 | 19,955 | 14,987 | 35,536 | 89,725 | 96,062 | 67,366 | 50,427 |
| Current assets | 67,109 | 83,306 | 92,530 | 160,352 | 82,854 | 73,452 | 84,395 | 96,471 |
| Total assets | 73,090 | 103,261 | 107,517 | 195,888 | 172,579 | 169,514 | 151,761 | 146,898 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 34,128 | 45,542 | 49,938 |
| Social insurance contributions | - | - | - | - | - | 16,346 | 18,927 | 23,599 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +20.9% | +12.0% | +9.9% | +11.7% | +4.8% | +11.9% | +8.4% | +4.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 9.5% | 17.0% | 8.3% | 5.4% | -6.9% | 5.2% | 11.6% | 5.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 15.5% | 28.8% | 12.6% | 13.0% | -17.3% | 11.5% | 18.6% | 7.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.2% | 5.0% | 2.3% | 2.5% | -2.6% | 1.7% | 3.2% | 1.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 2.6% | 5.9% | 2.7% | 2.5% | -2.6% | 1.8% | 3.3% | 1.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.6 | 0.7 | 0.5 | 1.4 | 1.5 | 1.2 | 0.6 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 78,572 | 88,031 | 96,788 | 96,069 | 90,580 | 101,403 | 109,879 | 114,255 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Mano augintinis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-11-21 | 2022-11-21 | 0.06 |
| 2022-11-17 | 2022-11-18 | 0.06 |
| 2022-10-28 | 2022-11-02 | 0.06 |
Mano augintinis - VMI tax arrears
As of 2026-10-07, the amount of overdue STI tax debt of the company Mano augintinis is: 0 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-28 | 2026-10-07 | 0.1 |
| 2026-09-18 | 2026-09-23 | 0.1 |
| 2025-09-19 | 2025-09-20 | 110.0 |
| 2025-04-06 | 2025-04-06 | 1364.33 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Mano augintinis, UAB (code 303176412) is a Private Limited Liability Company engaged in veterinary activities. In the latest financial year 2025, the company generated revenue of €571.3K, up 4.0% year on year and 12.7% over two years. Net profit was €7.6K, compared with €17.7K in 2024 and €8.9K in 2023, showing that profitability remained positive but weakened in 2025. The profit margin stood at 1.3%, below the 3.2% achieved in 2024. Total assets at the end of 2025 were €146.9K, with equity of €102.4K and liabilities of €44.5K. The equity ratio was 69.7% and debt-to-equity was 0.43, indicating a relatively solid capital structure. Asset turnover reached 3.89x, reflecting efficient use of assets in revenue generation. Return on equity was 7.4% and return on assets 5.2%. Revenue per employee was €114.3K, while profit per employee was €1.5K, consistent with modest but positive earnings in 2025.